insights_auto
Why is EDIT up 2.47%?
Dive Deeperchevron_right
EDIT:NASDAQ
Editas Medicine Inc
$1.87
arrow_upward
+2.47%(+0.045) 1D
Nov 18, 11:59:16 AM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EDIT...
Open
$1.86
High
$1.94
Low
$1.84
Mkt. cap
287.83M
Avg. vol.
2.39M
Volume
730.41K
52-wk high
$3.94
52-wk low
$1.66
EPS
-$0.62
Beta
2.09
Shares outstanding
154.34M
No. of employees
87
Open
$1.86
High
$1.94
Low
$1.84
Mkt. cap
287.83M
Avg. vol.
2.39M
Volume
730.41K
52-wk high
$3.94
52-wk low
$1.66
EPS
-$0.62
Beta
2.09
Shares outstanding
154.34M
No. of employees
87
News stories
From web sources and news partners
ChartMill
·
1 hour ago
S&P 500 Gap-Down Movers for Nov. 18 Session
TradingView
·
1 hour ago
S&P 500, Nasdaq find footing as Nvidia treads water
Invezz
·
4 minutes ago
UBS predicts S&P 500 moving up 12% in 2027 but flags major risks around AI
Proactive financial news
·
52 minutes ago
MARKETS LIVE: Dow losses deepen and S&P 500 turns lower as gold slides
Profile
Editas Medicine, Inc., is a clinical-stage biotechnology company that is developing therapies for rare diseases using CRISPR gene editing technology. Editas Medicine headquarters is located in Cambridge, Massachusetts with additional facilities in Boulder, Colorado. Wikipedia
About Editas Medicine Inc
CEO-
Employees87
FoundedNov 2013
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websiteeditasmedicine.com